Dr. Hiu Chun Lam completed his Ph.D. at the University of Adelaide under the supervision of A/Prof. Jonathan George, followed by postdoctoral training at Peking University under Professor Xiaoguang Lei. In 2020, Hiu joined the Molecular Imaging and Therapy Research Unit (MITRU) at the South Australian Health and Medical Research Institute (SAHMRI) as a radiochemist. In MITRU, Hiu develops the manufacturing process of radioisotopes and radiopharmaceuticals for clinical trials and special access schemes. He is also leading several pre-clinical projects including drug discovery program for novel radiopharmaceuticals.
AWS’s Artificial Intelligence is helping the Australian Epilepsy Project better understand epilepsy, and support doctors and patients in Australia make the diagnosis, treatment, and management of th
25 August 2024
Novel imaging methods combined with cognitive, genetic and medical data will use AI to increase the speed and accuracy of diagnoses and treatment for epilepsy patients, according to researchers workin
24 June 2024
10 April 2024
Researchers are developing a cutting-edge PET scan capable of assessing how well an individual human brain is cleaning itself, supported by NIF at SAHMRI. The radioisotopes required for the scans are
01 March 2024
Nicole Reyne, Ronan Smith, Patricia Cmielewski, Nina Eikelis, Mark Lawrence, Jennie Louise, Piraveen Pirakalathanan, David Parsons & Martin Donnelley
Read Publication
Parham Foroutan, Ryan D. Quarrington, Michael Pyrros Russo, Boyin Ding, Peter A. Cripton, John J. Costi, Claire F. Jones
Read Publication
Catherine G. Dimasi, Jack R.T. Darby, Stacey L. Holman, Megan Quinn, Ashley S. Meakin, Mike Seed, Michael D. Wiese, Janna L. Morrison
Read Publication
Esther Camp, Laura Gonzalez Garcia, Clara Pribadi, Sharon Paton, Krasimir Vasilev, Peter Anderson, Stan Gronthos
Read Publication